172 related articles for article (PubMed ID: 24172716)
1. Role of CYP3A in isoniazid metabolism in vivo.
Liu K; Li F; Lu J; Gao Z; Klaassen CD; Ma X
Drug Metab Pharmacokinet; 2014; 29(2):219-22. PubMed ID: 24172716
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity mechanisms of isoniazid: A mini-review.
Hassan HM; Guo HL; Yousef BA; Luyong Z; Zhenzhou J
J Appl Toxicol; 2015 Dec; 35(12):1427-32. PubMed ID: 26095833
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of isoniazid: The good, the bad, and the alternatives.
Erwin ER; Addison AP; John SF; Olaleye OA; Rosell RC
Tuberculosis (Edinb); 2019 May; 116S():S66-S70. PubMed ID: 31076322
[TBL] [Abstract][Full Text] [Related]
4. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
[TBL] [Abstract][Full Text] [Related]
5. Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis.
Dutt M; Khuller GK
Int J Antimicrob Agents; 2001 Feb; 17(2):115-22. PubMed ID: 11165115
[TBL] [Abstract][Full Text] [Related]
6. Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.
Zhou L; Song Y; Zhao J; Qin H; Zhang G; Zhou Y; Wu X
Pharm Biol; 2016; 54(6):931-7. PubMed ID: 26987268
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor.
Sarich TC; Adams SP; Petricca G; Wright JM
J Pharmacol Exp Ther; 1999 May; 289(2):695-702. PubMed ID: 10215642
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of isoniazid-induced hepatotoxicity: then and now.
Metushi I; Uetrecht J; Phillips E
Br J Clin Pharmacol; 2016 Jun; 81(6):1030-6. PubMed ID: 26773235
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver.
Wang P; Shehu AI; Lu J; Joshi RH; Venkataramanan R; Sugamori KS; Grant DM; Zhong XB; Ma X
Biochem Pharmacol; 2017 Dec; 145():218-225. PubMed ID: 28888949
[TBL] [Abstract][Full Text] [Related]
10. The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in Fischer 344 rats.
Mach J; Huizer-Pajkos A; Mitchell SJ; McKenzie C; Phillips L; Kane A; Jones B; de Cabo R; Cogger V; Le Couteur DG; Hilmer SN
Fundam Clin Pharmacol; 2016 Feb; 30(1):23-34. PubMed ID: 26454000
[TBL] [Abstract][Full Text] [Related]
11. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment.
Hassan HM; Guo H; Yousef BA; Guerram M; Hamdi AM; Zhang L; Jiang Z
Antimicrob Agents Chemother; 2016 Sep; 60(9):5285-93. PubMed ID: 27324775
[TBL] [Abstract][Full Text] [Related]
12. Isoniazid: metabolic aspects and toxicological correlates.
Preziosi P
Curr Drug Metab; 2007 Dec; 8(8):839-51. PubMed ID: 18220565
[TBL] [Abstract][Full Text] [Related]
13. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure.
Metushi IG; Sanders C; ; Lee WM; Uetrecht J
Hepatology; 2014 Mar; 59(3):1084-93. PubMed ID: 23775837
[TBL] [Abstract][Full Text] [Related]
14. Circadian variation in murine hepatotoxicity to the antituberculosis agent «Isoniazide».
Souayed N; Chennoufi M; Boughattas F; Haouas Z; Maaroufi K; Miled A; Ben-Attia M; Aouam K; Reinberg A; Boughattas NA
Chronobiol Int; 2015; 32(9):1201-10. PubMed ID: 26479844
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.
Lian Y; Zhao J; Xu P; Wang Y; Zhao J; Jia L; Fu Z; Jing L; Liu G; Peng S
PLoS One; 2013; 8(8):e72058. PubMed ID: 23967274
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana).
Maslow JN; Mikota SK; Zhu M; Isaza R; Peddie LR; Dunker F; Peddie J; Riddle H; Peloquin CA
J Vet Pharmacol Ther; 2005 Feb; 28(1):21-7. PubMed ID: 15720511
[TBL] [Abstract][Full Text] [Related]
18. CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid.
Cheng J; Krausz KW; Li F; Ma X; Gonzalez FJ
Toxicol Appl Pharmacol; 2013 Jan; 266(2):245-53. PubMed ID: 23142471
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: Activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway.
Jia ZL; Cen J; Wang JB; Zhang F; Xia Q; Wang X; Chen XQ; Wang RC; Hsiao CD; Liu KC; Zhang Y
Chemosphere; 2019 Jul; 227():541-550. PubMed ID: 31004821
[TBL] [Abstract][Full Text] [Related]
20. Is isoniazid-hepatotoxicity induced by the metabolite, hydrazine?
Noda A; Hsu KY; Noda H; Yamamoto Y; Kurozumi T
J UOEH; 1983 Jun; 5(2):183-90. PubMed ID: 6679629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
